Stockreport

KalVista Pharmaceuticals Presents New Data Highlighting the Potential of EKTERLY® (sebetralstat) to Transform On-Demand Hereditary Angioedema Treatment in Europe [Yahoo! Finance]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF FRAMINGHAM, Mass. & SALISBURY, England, October 06, 2025 BUSINESS WIRE KalVista Pharmaceuticals , Inc. (Nasdaq: KALV) today announced new data from its KONFIDENT and KO [Read more]